http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9314435-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89d397e2fff9dece10c981cc12cb9f06
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-232
filingDate 2012-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18bbbae1d9a41bf0bb0a8432fad05de8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fa68cbb7510b3ae39258fd548a7178c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8723fed093965d8615d56d26471bb651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06290f489a6d347519ee6b933395f99d
publicationDate 2016-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9314435-B2
titleOfInvention Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules
abstract The invention discloses stable formulations of acetylsalicylic acid or salts thereof, omega-3 fatty acids and amylose in soft gelatin capsules.
priorityDate 2011-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009192126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011060944-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3456051-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008025819-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003199481-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008068276-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9209274-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010178335-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6437059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23623894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428

Total number of triples: 60.